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Abstract Friedreich’s ataxia is caused by a de¢cit in the mi-
tochondrial protein frataxin. The present work demonstrates
that in vivo yeast frataxin Yfh1p and Isu1p, the mitochondrial
sca¡old protein for the Fe^S cluster assembly, have tightly
linked biological functions, acting in concert to promote the
Fe^S cluster assembly. A synthetic lethal screen on high iron
media with the mild G107D yfh1 mutant has speci¢cally iden-
ti¢ed Isu1p. Analysis of the cellular phenotypes resulting from
pairwise combinations of yfh1 and isu1 mutations, and cross-
linking experiments in isolated mitochondria provide evidence
for a direct interaction between Yfh1p and Isu1p.
* 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Reduced levels of human frataxin cause Friedreich’s ataxia
(FA), a recessive neurodegenerative disorder often associated
with cardiomyopathy [1,2]. An early observation was that
frataxin de¢ciency results in a speci¢c defect of the Fe^S pro-
teins in Friedreich patients [3]. Lack of Fe^S protein activity
may be caused by either oxidative damage to labile Fe^S
clusters (ISCs) or alteration of the ISC synthesis which has
been shown to occur within mitochondria through an ISC
machinery strongly conserved during evolution [4]. Although
there is good evidence that frataxin plays a role in the anti-
oxidant signalling pathway [5] several recent data argue for a
direct role of frataxin in the ISC machinery. First, it has been
shown in yeast and transgenic mice that in the absence of
mitochondrial iron accumulation the activity of Fe^S proteins
is not restored, implying that iron-induced damage is not the
primary cause of the ISC defect [6,7]. Second, the synthesis of
ISCs is substantially decreased in isolated mitochondria and
in mitochondrial extracts of frataxin-de¢cient or conditionally
frataxin-depleted strains [8,9]. Third, recombinant puri¢ed
frataxins from yeast, bacteria and humans bind iron in vitro
[10^12]. Finally, it has recently been reported that in vitro
human holo-frataxin binds six to seven iron ions and mediates
the transfer of the bound iron to ISU [13], a key component
of the ISC machinery. In the presence of iron and sulfur
provided by a cysteine desulfurase [14,15], ISU is used as a
sca¡old for the transient assembly of a [2Fe^2S] cluster
[16,17]. In addition, a very recent report shows that yeast
frataxin expressed as a glutathione-S-transferase fusion mito-
chondrial protein can be puri¢ed by a⁄nity chromatography
as a complex containing Isu1p and the Nfs1p cysteine desul-
furase [18]. These in vitro and biochemical studies require
biological in vivo support. Here we report the results of a
blind search using a synthetic lethality screen for proteins
functionally interacting with yeast frataxin.
2. Materials and methods
2.1. Strains, plasmids and media
Saccharomyces cerevisiae strains are isogenic to W303-1B (MATK
ade2-1 leu2-3,112 his3-11,15 ura3-1 trp1-1), or are haploid meiotic
segregants from crosses between W303-1B and W303-1A (MATa)
derivatives. The names of the strains are in capital letters (vYFH1,
G60D T) and those of the alleles are in italic letters (yfh1v, isu1 T).
Mutants A77T, A94P, G107D, P125S, L162F, M21I and E53L were
obtained by in vitro hydroxylamine mutagenesis of the centromeric
pFL39/YFH1 plasmid [19] followed by transformation of vYFH1
strain (MATK ade2-1 leu2-3,112 his3-11,15 ura3-1 trp1-1 yfh1v : :
KanR) with the pool of mutagenized plasmids and screening for clones
unable to grow on 10 mM FeSO4 at 37‡C. All isu1 alleles, including
G60D and M141V, which were obtained by site-directed mutagenesis
[20], are borne by the centromeric pRS313 plasmid. All polymerase
chain reaction (PCR) products were veri¢ed by DNA sequencing.
The vISU1 strain was obtained in strain W303-1B by replacing the
coding region and £anking sequences (361 bp to +289 bp relative to
the ATG start codon) by the URA3 gene. The correct integration of
the URA3 cassette at the ISU1 locus was con¢rmed by PCR. Mutants
A77T vISU1, A94P vISU1, G107D vISU1, P125S vISU1 and L162F
vISU1 were isolated as follows. Firstly, strain vYFH1-3C (MATa
leu2-3,112 his3-11,15 ura3-1 trp1-1 yfh1v : :KanR) was transformed
with pFL39 plasmids bearing the yfh1 mutations, secondly, the trans-
formed strain was crossed with the vISU1 strain, and yfh1v isu1v
meiotic segregants harboring a pFL39-borne yfh1 allele were selected.
These mutants have also been transformed with pRS313, pRS313/
ISU1, pRS313/M141V, pRS313/G60D-M141V and pRS313/G60D
plasmids.
The strains were grown in 2% glucose minimum solid medium, or in
2% ra⁄nose synthetic liquid medium. The media were supplemented
with FeSO4 at the indicated concentration.
2.2. Mitochondria isolation, enzyme activities, Western analysis, ISC
incorporation into Yah1p and disuccinimidyl glutarate (DSG)
cross-linking
Mitochondria were prepared from cells grown to late exponential
phase in synthetic ra⁄nose medium after sphaeroplast lysis [8]. Aco-
nitase and isocitrate dehydrogenase activities were measured by stan-
dard procedures. ‘Non-heme and non-Fe^S’ iron concentration was
measured using bathophenantroline disulfonic acid [21]. Levels of
aconitase, Yfh1p, and Isu1p/Isu2p were determined by Western blot-
ting using polyclonal antibodies raised against yeast aconitase and
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Yfh1p, and Escherichia coli IscU (a gift from L.E. Vickery, University
of California, Irvine, CA, USA). Import of 35S-radiolabeled apo-
Yah1p into isolated mitochondria and incorporation of ISC into ma-
ture Yah1p were performed exactly as described [8]. Chemical
amounts (V5 Wg) of puri¢ed apo-Yah1p overexpressed in E. coli
were used in the assay using 35S-cysteine [8]. After mitochondrial lysis,
apo- and holo-Yah1p were separated on native acrylamide gels, de-
tected by autoradiography of the dried gels and the signals were
quanti¢ed.
For cross-linking experiments 35S-Yfh1p and 35S-Isu1p synthesized
in vitro (Promega) were imported into mitochondria (V150 Wg pro-
tein in 200 Wl of import bu¡er, pH 7.4) [8]. After a 10 min incubation
at 23‡C, 2 Wl of 20 mM DSG solution in dimethylsulfoxide (DMSO)
was added to reach a ¢nal concentration of 200 WM and 2 Wl DMSO
was added to mocked samples. After a 30 min incubation at 23‡C,
cross-linking was quenched by 50 mM Tris^HCl, pH 7.5, and mito-
chondria were washed twice by centrifugation in 1 ml of a bu¡er
containing 0.6 M sorbitol, 50 mM KCl and 20 mM Tris^HCl, pH
7.4. The mitochondrial suspension was then incubated on ice for 30
min with 200 Wg/ml proteinase K, proteinase K was inactivated with
2 mM phenylmethylsulfonyl £uoride acid and the mitochondria were
extensively washed in the same bu¡er as above.
3. Results
3.1. A synthetic lethal screen identi¢ed ISU1 as a genetic
YFH1 partner
Our goal was to identify genes functionally related to YFH1
by searching extragenic mutations causing lethality on iron
media in the presence of a mild yfh1 mutation. First, we iso-
lated seven yfh1 mutants with impaired growth on 7 mM
FeSO4 at 37‡C (Fig. 1A). M21I and E53L mutations are
located in the mitochondrial targeting presequence, and
A77T, A94P, G107D, P125S and L162F are scattered in the
mature protein. All mutants had mild phenotypes. Their cel-
lular growth at 28‡C on 7 mM FeSO4 was wild-type (or al-
most wild-type) while that of strain vYFH1 was inhibited
(Fig. 1A). In A94P, the most a¡ected mutant, the aconitase
activity, which re£ects ISC machinery activity, was decreased
by 50% and mitochondrial iron content was 2.5-fold higher
than in wild-type (data not shown). Under these conditions,
the mitochondrial iron content of the vYFH1 strain was 10
times higher than in wild-type and aconitase activity was less
than 15%.
Mutant G107D was chosen to perform the in vivo ethyl-
methanesulfonate mutagenesis and synthetic lethal screen.
This mutant has the mildest phenotype and is modi¢ed in a
conserved residue whose Gly130 equivalent in humans is re-
placed by a valine in an atypical form of FA [22]. The present
work is focused on one of the synthetic lethal mutants ob-
tained on 7 mM FeSO4 at 28‡C. In this mutant the pFL39/
G107D plasmid could not be lost, suggesting that it was re-
quired for cell survival. The mutated gene causing synthetic
lethality was identi¢ed by cellular growth restoration on 10
mM iron media at 28‡C after transformation with a high copy
number genomic library that did not contain the YFH1 gene.
Sequencing of the complementing plasmid inserts revealed the
complete sequences of ISU1 (one insert), and ISU2 (¢ve in-
dependent inserts). Isu1p is the major form, and Isu2p, whose
mature form is quite similar to Isu1p (85% amino acid se-
quence identity), is not detectable in cells grown to stationary
phase [23]. Although neither ISU1 nor ISU2 are essential
genes, the double isu1v isu2v deletion is lethal [23^24]. The
isu1 and isu2 genes from the synthetic lethal mutant were
cloned by gap-repair and sequenced. No mutation was present
in ISU2, which behaves as a multicopy suppressor, while two
amino acid modi¢cations G60D and M141V were identi¢ed in
isu1.
To determine the contribution of each isu1 mutation to the
increase in iron sensitivity, ISU1, G60D, M141V and G60D-
M141V alleles were cloned in the pRS313 centromeric plasmid
in a wild-type YFH1 context, and compared with an isu1
deletion. The M141V mutation did not confer any phenotype,
while the G60D mutation was su⁄cient for slower cellular
growth on 4 mM FeSO4 (Fig. 1B). Curiously, the G60D-
M141V mutant was sicker than the vISU1 mutant, indicating
that the G60D-M141V allele is not silent.
3.2. G107D yfh1 and isu1 mutations have synergetic deleterious
e¡ects on ISC assembly
Although mutants carrying either yfh1v or isu1 mutation
alone (isu1v, G60D or G60D-M141V) were viable, tetrad
analysis showed that the combination of both yfh1v and
isu1 mutations in the same strain was lethal (V120 tetrads).
In contrast, spores containing yfh1v and isu2v alleles were
readily obtained. This synthetically lethal trait underlines the
tight functional link between Yfh1p and Isu1p, and indicates
that Isu2p cannot substitute for Isu1p in a strain that has no
frataxin.
However, spores containing yfh1 G107D and isu1v muta-
tions together were viable. Nevertheless, although mutants
harboring the isu1 deletion or G107D yfh1 mutation alone
Fig. 1. Cellular growth phenotypes on iron-containing glucose minimum media. A: yfh1 mutants were incubated on 7 mM FeSO4 for 3 days
at 28‡C or 37‡C. B: Twenty-fold serial dilutions of isu1v cells harboring the pRS313 plasmid-borne ISU1, G60D, M141V, G60D-M141V alleles
or empty pRS313 plasmid (vISU1). C: High iron sensitivity of G107D vISU1 mutant compared to G107D or vISU1 mutants (serial dilutions).
D: Synergetic e¡ects in mutants combining yfh1 and isu1 mutations (serial dilutions). The yfh1v isu1v strains have been transformed with both
pFL39 plasmids harboring the di¡erent yfh1 mutations and pRS313 plasmids, either empty (vISU1), or harboring ISU1, G60D, G60D-M141V,
or M141V mutations. On top of each panel the yfh1 mutation is indicated and the combination with isu1 mutations is shown on the left.
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were not severely a¡ected, the combination of both mutations
in the same strain led to severe phenotypes in the presence of
4 mM FeSO4 (Fig. 1C). To better understand the functional
link between Isu1p and Yfh1p we compared the biochemical
properties of mutants carrying either one or two mutated
genes. The mitochondrial iron content and aconitase activity
of the G107D yfh1 mutant in a wild-type ISU1 context were
quite similar to that of the parental strain (Fig. 2A,B). We
also measured the incorporation rate of ISCs into the mito-
chondrial Yah1p ferredoxin imported into isolated mitochon-
dria. The apo- and holo-forms of Yah1p can be distinguished
by their mobility in native gel electrophoresis. Fig. 3 shows
that the conversion rate of the apo- to holo-form was not
a¡ected in the G107D mutant, compared to the strong de-
crease observed in the vYFH1 mutant.
Surprisingly, G107D Yfh1p levels estimated by Western
blot analysis were very low, though detectable (Fig. 2C). All
mutants except P125S (data not shown) had low Yfh1p levels,
suggesting a reduction in frataxin stability. This is in agree-
ment with the thermosensitive phenotype of the mutants and
the prediction that the mutated residues play a role in the
structure of the protein. It has been shown that human
G130V frataxin is also unstable [25^26]. Moreover, puri¢ed
wild-type Yfh1p compared to E. coli and human frataxins has
an unusually low melting temperature [11] so that any muta-
tion in the protein could increase its instability. Our data led
to the conclusion that minute amounts of frataxin are su⁄-
cient to support ISC assembly in mitochondria.
The vISU1 mutant had slightly increased mitochondrial
iron content and its aconitase activity was decreased by
V50% (Fig. 2A,B). Therefore, in the vISU1 mutant the low
amounts of Isu2p (20% of Isu1p) support ISC synthesis at a
rate which is not optimal but still substantial.
However, when isu1v and G107D yfh1 mutations were put
together the mitochondrial iron concentration was consider-
ably increased and aconitase activity was extremely low (Fig.
2D,E). Aconitase protein levels were strongly reduced (Fig.
2F). Low levels of aconitase were also observed in our
vYFH1 strain grown in glucose medium (data not shown).
They correlate with severe in vivo phenotypes and are not the
result of decreased ACO1 transcript levels. A likely explana-
tion is that under extremely low ISC assembly conditions
aconitase is mainly under its apo-form, a protein state recog-
nized and degraded by the proteases in charge of the mito-
chondrial protein quality control [27].
Altogether, these data show yfh1 and isu1 mutations act
Fig. 2. Synergetic deleterious e¡ects on mitochondrial iron content and aconitase activity in the doubly mutated strain G107D vISU1 compared
to the single gene mutation strains G107D and vISU1. Mitochondria were isolated from cells grown in ra⁄nose medium in the presence of
5 WM FeSO4. Panels A^C illustrate single gene mutation strains, and panels D^F illustrate strains mutated in both yfh1 and isu1 genes. The
wild-type strain is W303-1B. The values represent the average of six measurements from three independent cultures and can be compared di-
rectly in all mutants. The average mitochondrial iron content of wild-type is 12 nmol/mg protein.
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synergically. Low levels of frataxin have no signi¢cant conse-
quence on ISC synthesis in a wild-type ISU1 context. Low
levels of Isup have only a moderate e¡ect in a wild-type
YFH1 context. However, the combination of low levels of
both proteins has dramatic e¡ects. This indicates that frataxin
becomes essential when Isup levels are limiting, and acts in
concert with Isu1p to promote ISC assembly.
The situation was more complex with the G60D-M141V
allele. In a wild-type YFH1 context this double mutation
had more dramatic e¡ects than the isu1v allele (Fig. 2A,B).
This severe phenotype is most likely the result of the wild-type
expression level of the non- (or poorly) functional G60D-
M141V Isu1p (Fig. 2C) competing in a deleterious manner
with the functional Isu2p. Curiously, ISC metabolism was
less a¡ected in G107D G60D-M141V than in G107D vISU1
strain (Fig. 2D,E). We have currently no explanation for this
observation, which, however, suggests that when G60D-
M141V Isu1p and G107D Yfh1p are together in the mito-
chondria, they in£uence the activity of each other.
3.3. Synthetic lethality of isu1-1 and yfh1 mutations on iron-
containing media is not correlated with yfh1 mutant
phenotype severity
To determine whether the severe phenotype of the G107D
vISU1 mutant was allele speci¢c, we generated a set of yfh1
isu1 mutants containing pairwise combinations of G60D,
G60D-M141V isu1 or isu1v mutations and A77T, A94P,
P125S or L162F yfh1 mutations, respectively. In all pairwise
combinations, cellular growth sensitivity to iron was substan-
tially increased compared to single gene mutations. However,
there was no direct relationship in the severity of the pheno-
types obtained with one or two mutated genes (Fig. 1D). A
speci¢cally severe phenotype was observed when the G60D
isu1 mutation was combined with the mild A77T and L162F
yfh1 mutations. Cellular sensitivity to iron was even more
pronounced than for G60D isu1 A94P (or P125S) yfh1 com-
bination, although alone these yfh1 mutations were much
more severe. Moreover, A77T G60D and L162F G60D mu-
tants were sicker than A77T G60D-M141V and L162F G60D-
M141V mutants, respectively, although when alone, G60D-
M141V isu1 was more severe than G60D isu1. Therefore,
although the mutant phenotypes can roughly be explained
by low levels of Yfh1p, the more subtle di¡erences observed
between di¡erent combinations of yfh1 and isu1 mutations
suggest that the function of Yfh1p is in£uenced by the muta-
tion(s) in Isu1p, and vice versa, as a result of a physical
interaction between the two proteins.
3.4. A cross-linking product of same mobility whose formation
depends on functional ISC machinery is shared by Yfh1p
and Isu1p imported into isolated mitochondria
35S-radiolabelled Yfh1p and Isu1p were imported into iso-
lated mitochondria, and mitochondria were treated with
DSG, a non-cleavable cross-linking agent penetrating the mi-
tochondrial membranes. A V43 kDa cross-linking product
was shared by imported 35S-Yfh1p and 35S-Isu1p in wild-
type mitochondria (Fig. 4A). It was absent in vYFH1 and
G107D mitochondria containing imported 35S-Isu1p (Fig.
4A,B), or in vISU1 mitochondria containing 35S-Yfh1p
(Fig. 4C). These data suggest that the 43 kDa product con-
tains cross-linked Yfh1p and Isu1p, an interpretation sup-
ported by the observation that cross-linking did not occur
when endogenous frataxin or Isup were either absent
(vYFH1), or in too low amounts (G107D, vISU1) to have
some chance of interacting with the 35S-radiolabelled im-
ported protein. Curiously, the apparent mobility of the
cross-linking product (43 kDa) was substantially slower than
that of each of the two species (apparent mass of 20 kDa for
Yfh1p and 15 kDa for Isu1p). This discrepancy might result
from abnormal mobility caused by cross-linking. Another hy-
pothesis would be that the V43 kDa product results from
cross-linking between a Yfh1p monomer and an Isu1p dimer.
In several organisms, holo-Isup/IscU are homodimers [28^29].
Surprisingly, the cross-linking product was not detectable in
Fig. 3. Incorporation of ISC into mature Yah1p ferredoxin imported into energized isolated mitochondria of wild-type, G107D and vYFH1
strains grown in ra⁄nose medium. Import of apo-Yah1p into mitochondria determined by SDS^PAGE was identical in all strains (not shown).
A: Incorporation of ISC into mature 35S-labeled Yah1p. The amount of holo-Yah1p was expressed as the ratio of holo-Yah1p to apo- plus
holo-Yah1p. B: Incorporation of Fe^35S cluster into mature Yah1p present in chemical amounts in the assay. The ISC was radiolabeled in mi-
tochondria as reported [8] with 35S-cysteine added to the assay.
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vYFH1 mitochondria containing 35S-Yfh1p. We believe that
the absence of the 43 kDa product in vYFH1 mitochondria
re£ects impaired ISC assembly. This interpretation is sup-
ported by the observation that in G107D mitochondria that
have a functional ISC machinery, though small amounts of
endogenous Yfh1p, the cross-linking product is made in the
mitochondria containing imported 35S-Yfh1p (Fig. 4B).
4. Discussion
Our blind search for Yfh1p partners has identi¢ed Isu1p
and no other member of the ISC machinery. Therefore, we
can conclude that Isu1p is most likely the major partner of
frataxin in mitochondria.
Recent in vitro studies have shown that an iron-bound form
of human frataxin forms a high a⁄nity complex with human
ISU1 and is able to mediate the transfer of iron to ISU [13].
Moreover, very recently it has been shown that Yfh1p ex-
pressed in mitochondria as a glutathione-S-transferase fusion
protein can be puri¢ed by a⁄nity chromatography as a com-
plex composed of Isu1p and Nfs1p [18]. These in vitro and
biochemical data were based on the a priori assumption that
frataxin and ISU interact. Our present work gives the biolog-
ical support that was missing, and also provides further in-
sight into the relationship between Yfh1p and Isu1p.
A cell that has no frataxin and low levels of Isu2p is not
viable, and a cell that has low levels of frataxin and Isu2p is
very sick. However, in a wild-type ISU1 context very low
levels of frataxin are su⁄cient to support e⁄cient ISC assem-
bly, and cells without frataxin are still able to synthesize ISCs
though much less e⁄ciently [8]. Thus, in yeast frataxin does
not play an essential role as long as Isup is not in limiting
amounts. This suggests that frataxin assists Isu1p for an op-
timal function. Here, it must be stressed that the yeast model
cannot be applied directly to humans or mice, for which fra-
taxin is essential [2,7]. The interallelic interactions observed in
pairwise combinations of yfh1 and isu1 mutations are strongly
suggestive of physical interactions between the two proteins,
and conclusions of this in vivo approach are still strengthened
by in organello experiments strongly suggesting cross-linking
between Yfh1p and Isu1p in intact mitochondria treated with
DSG. These data support the in vitro ¢nding that frataxin can
mediate the transfer of iron to ISU [13]. However, since total
loss of frataxin in glycerol-grown cells only partially a¡ects
ISC synthesis [8,30], this implies that another mitochondrial
source of iron is available, which is still to be discovered.
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